Evidence map›Paper›PMID 35656207›Full record

ArticlePreventive medicine reports2022

Ten-year changes in colorectal cancer screening in Switzerland: The Swiss Health Interview Survey 2007, 2012 and 2017.

Rémi Schneider, Lamprini Syrogiannouli, Sarah Bissig, Tamara Scharf, Jean-Luc Bulliard, Cyril Ducros, Cinzia Del Giovane, Kali Tal, Marcel Zwahlen, Kevin Selby and 1 more

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Preventive medicine reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 9 papers.

0numbers the graph read from it
0cells of the map it votes in
9citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

9 citing papers in PubMed.

  1. Trial
  2. Trial
  3. Article
  4. Article
  5. Listening to patients: A qualitative study on diagnostic delay, coping strategies and stigma in early-onset colorectal cancer.Colorectal disease : the official journal of the Association of Coloproctology of Great Britain and Ireland · 2025
    Article
  6. Review
  7. Article
  8. Review
  9. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors.

Rémi SchneiderInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Lamprini SyrogiannouliInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Sarah BissigInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Tamara ScharfInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Jean-Luc BulliardCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Cyril DucrosCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Cinzia Del GiovaneInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Kali TalInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.
Marcel ZwahlenInstitute of Social and Preventive Medicine (ISPM), University of Bern, Bern, Switzerland.
Kevin SelbyCenter for Primary Care and Public Health (Unisanté), University of Lausanne, Lausanne, Switzerland.
Reto AuerInstitute of Primary Health Care (BIHAM), University of Bern, Bern, Switzerland.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Recent recommendations for colorectal cancer (CRC) screening suggest fecal occult blood test (FOBT) or colonoscopy. Since 2013, mandatory health insurance in Switzerland reimburse CRC screening. We set out to determine if CRC testing rate and type of CRC screening changed in Switzerland from 2007 to 2017 and between the three main language regions. We extracted data on 50-75-year-olds from the Swiss Health Interview Survey (SHIS) 2007, 2012 and 2017 to determine rates of self-reported testing with FOBT within last 2 years and colonoscopy within last 10 years. We estimated prevalence ratio (PR) in multivariate-adjusted logistic regression models and compared rates in German-, French- and Italian-speaking regions, adjusting for sociodemographic, self-rated health and insurance variables. Overall testing rates (FOBT or colonoscopy) increased in all regions from 2007 to 2017 (German-speaking 33.6% to 48.3%; French-speaking 30.8% to 48.8%; Italian-speaking 37.9% to 46.8%), mainly because of an increase in colonoscopy rate for screening reasons (p < 0.001 in all regions). Rates of FOBT testing fell significantly in the German-speaking region (11.9% to 4.4%, p < 0.001), but not in the Italian- (13.9% to 8.5%, p = 0.052) and French-speaking regions (7.6% to 7.4%, p = 0.138). Overall CRC testing rate rose from 33.2% in 2007 to 48.4% in 2017, mainly because of an increase of colonoscopy rate for screening reasons. Coverage remains below the 65% target of European guidelines. Organized screening programs encouraging FOBT screening could contribute to further increasing the CRC testing rate.

Indexed as

CHF, Swiss francColonoscopyColorectal cancer screeningCRC, Colorectal CancerFecal occult blood test (FOBT)FIT, fecal immunochemical TestFOBT, Fecal occult blood testHDHP, High deductible health planHMO, Health Maintenance OrganisationLDHP, Low deductible health planSFSO, Swiss Federal Statistics OfficeSHIS, Swiss Health Interview SurveySwitzerland

Identifiers

PMID35656207
PMCPMC9152794

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.